Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 349165

AbstractDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Reviews
Year : 2024 | Month : August | Volume : 18 | Issue : 8 | Page : ZE01 - ZE07 Full Version

Oral Epithelial Dysplasia: A Narrative Review on Histological Grading, Computer-aided Diagnostics and Treatment Approaches


Published: August 1, 2024 | DOI: https://doi.org/10.7860/JCDR/2024/71109.19727
Taibur Rahman, Lipi B Mahanta

1. Ph.D. Scholar, Department of Mathematical and Computational Sciences (MCS), Institute of Advanced Study in Science and Technology, Guwahati, Assam, India; Academy of Scientific and Innovative Research (AcSIR), AcSIR Headquarters CSIR-HRDC Campus, Ghaziabad, Uttar Pradesh, India. 2. Associate Professor, Department of Mathematical and Computational Sciences (MCS), Institute of Advanced Study in Science and Technology, Guwahati, Assam, India; Academy of Scientific and Innovative Research (AcSIR), AcSIR Headquarters CSIR-HRDC Campus, Ghaziabad, Uttar Pradesh, India.

Correspondence Address :
Taibur Rahman,
Ph.D. Scholar, Department of Mathematical and Computational Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati-781036, Assam, India.
E-mail: taiburat8@gmail.com

Abstract

Head and Neck (H&N) cancer represents a significant global health burden, ranking sixth among all cancer types worldwide, with a particularly high prevalence in developing countries. Oral cancer, a subset of H&N cancer, encompasses malignant growths within the oral cavity region. Oral Epithelial Dysplasia (OED) serves as a precursor lesion to oral cancer and is identifiable through histological examination by pathologists. While histological grading correlates with progression cancer risk, accurately predicting lesion advancement remains challenging due to limited research and study. Despite established grading criteria based on architectural and cytological changes in the oral cavity histological images, variability exists among pathologists in assessing OED presence and grade. The present article explores OED as a precancerous lesion, delving into various histological grading systems based on architectural and cytological changes. Additionally, it examines the role of Computer-aided Diagnostics (CAD) leveraging Artificial Intelligence (AI) in OED detection. Lastly, the paper discusses treatment modalities for oral cavity cancers.

Keywords

Artificial intelligence, Cancer prevention, Dysplasia grading, Oral cancer, Treatments

A healthy mouth is a one-of-a-kind and priceless asset that is also an integral part of overall health and quality of life; it can even be considered a basic human right. In reality, oral health is frequently compromised every day by various types of diseases, including dental caries, periodontal disease, and, in rare cases, oral cancer, lesions caused by Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS), conditions of the mucosa and salivary glands, as well as a variety of pains and clefts (1). Currently, oral diseases are recognised as a worldwide epidemic and a major public health issue that affects almost every individual throughout their lives (2). Oral cancer ranks as the 11th most common cancer worldwide. One of the leading causes of death in India is oral cancer, which affects a large segment of the population (3). The United States projects 2,001,140 new cancer cases and 611,720 cancer-related deaths for 2024 (4), with a sustained decline in mortality attributed to factors such as reduced smoking rates, advancements in early detection, and enhanced treatment options. The overall cancer mortality rate has dropped by 31% since 1991, resulting in 3.2 million fewer cancer deaths. Men are more than twice as likely as women to develop oral and oropharyngeal cancers. White people are slightly more likely than Black people to be affected. Overall, men have a one in 60 (1.7%) lifetime risk of developing oral cavity and oropharyngeal cancer, while women have a one in 140 (0.71%) lifetime risk of developing oral cavity and oropharyngeal cancer. Men’s cancer rates are more than twice as high as women’s (5).

In the present article, the author discusses the risk factors of oral cancer, the statistics relating to oral cancer incidence in India according to various socio-economic positions, and the different diagnostic techniques routinely used to detect oral cancer (6). Most of the sources for oral cavity cancers are associated with tobacco, areca nuts, Human Papillomavirus (HPV), and excessive alcohol habits. Good oral health begins with good oral hygiene, such as using fluoride toothpaste, flossing daily, and seeking professional help if necessary. Oral health is also affected by social determinants. Ideally, the dentist-to-population ratio should be 1:7500 according to the World Health Organisation (WHO), but in India, it is 1:22,500, which is shocking. Higher disease rates occur in racial/ethnic groups and people with lower education and income (7). Reagon coined the term “dysplasia” to describe the cells exfoliated from uterine cervix lesions in 1958 (8). Once upon a time, epithelial dysplasia, epithelial atypia, and dyskeratosis were all interchangeable terms. The term dysplasia is used to describe the presence of abnormality within a tissue. Truly, Dysplasia is not cancer, but it may sometimes become cancer. Dysplasia of the oral cavity is a potentially precancerous lump diagnosed histologically (9). In oral dysplasia, significant changes in tissue layers and cells can be observed under the microscope, representing a premalignant stage for epithelial carcinomas, for example, Oral Squamous Cell Carcinoma (OSCC). OSCC consists of the oral cavity, nasal cavity, oropharynx, paranasal sinus, larynx, hypopharynx, nasopharynx, tonsils, tongue, salivary glands, parotid glands, and lip (10). In medical terms, dysplasia is used to describe the premalignant or precancerous stage of epithelial malignancies, such as OSCC, which is caused by a variety of hereditary and environmental variables that result in the proliferation of atypical epithelium. A study (9), discussed various imaging methods for the detection of dysplasia in the oral epithelium of the oral cavity region, which is examined here using the cytological and architectural changes in the epithelium. OED is often a precancerous lesion, and it can be classified into mild, moderate, and severe forms (11). More recently, a two-tier grading system has been developed (12). However, this two-tier grading system is done for a better understanding of histopathology OED by the clinician in a practical approach. Histopathology has long been thought to be incongruent in the diagnosis and classification of OED, with low inter- and intraobserver agreement and reproducibility (13). OED is not hereditary, so it can affect anyone at any stage who is exposed to tobacco and heavy alcohol. A precancerous lesion called OED is an element of potential cancer development within the oral mucosa (14). A cellular and morphological change found in OED remains a significant risk factor for invasive neoplasia later in life. Precancer lesions cause cancer cells to grow in their immediate surroundings.

In the past, Oral Potentially Malignant Disorders (OPMD) were referred to as potentially malignant lesions or conditions. These disorders mostly involve leukoplakia and erythroplakia (15),(16).

A comprehensive search was conducted across multiple databases, including PubMed, Web of Science, IEEE, Embase, Cochrane Library, Wiley Online Library, and Europe PMC. The search terms encompassed various aspects of oral cavity cancer, oral dysplasia, OED, classification or grading of OED, potentially malignant disorders, CAD, and their combinations. After eliminating duplicates, a total of 1080 papers were identified, of which 153 were deemed relevant while 927 were considered irrelevant. Among the relevant papers, 110 were available in full text. From there, the author selected 11 papers specifically related to OED. The review encompassed studies on oral cancer histological grading by different authors, oral cancer epidemiology, CAD, Artificial Intelligence (AI) and cancer treatments.

Discussion

Histological Grading

The term dysplasia was coined in the 1950s to describe uterine cervix pathology (17). In 1968, the Cervical Intraepithelial Neoplasia (CIN) grading system was established as the first widely used histological grading system for dysplasia by the WHO in 2014. It consists of three grades- CIN1 (mild), CIN2 (moderate), and CIN3 (severe). The successful implementation of this system influenced the grading of dysplasia in various tissues, including the oral mucosa, for decades (17),(18). Pathologists grade OED by assessing the dysplastic features of the lesions. In the grading system, numerous dysplastic features are utilised, making it challenging to determine the degree of epithelial dysplasia. The most common change to the oral mucosa is squamous cell carcinoma of the mouth (19). Among potentially malignant disorders, leukoplakia is the most prevalent (20). Various dysplastic features are employed in grading systems, which complicates rating the degree of dysplasia accurately. Some grading systems suggest assessing mild, moderate, and severe dysplastic features (9). Recently, efforts have been made to define more precise grading criteria for OED (21),(22). According to the author, no research has revealed any natural prognostic groups or characteristic clustering to establish unique OED patterns (23). The main goal of this work, as per the article, is to implement a transfer learning method for classifying images as “suspicious” or “normal” using Inception-ResNet-V2. Heat maps are then generated to highlight the regions of the images that are most likely to be involved in decision-making. Their developed approaches are also tested with two independent clinical photographic image datasets of 30 and 24 patients from the UK and Brazil, respectively (24).

In the CIN grading system, mild dysplasia is characterised by cytological changes limited to the basal third of the epithelial thickness, while CIN2 and CIN3 are associated with the middle and upper thirds, respectively (18),(25). However, according to molecular analysis of cervical disease, CIN1 is biologically distinct from CIN2 and CIN3 (26). The following are the most commonly used grading systems proposed for OED by various authors and organizations, with the grading system criteria and grades presented chronologically in (Table/Fig 1) (12),(22),(27),(28),(19),(20),(31),(32),(33),(34). A study conducted by Shubhasini AR et al. (35), evaluated the degree of agreement between two pathologists in grading the inter and intraobserver variability of dysplasia in the same patients. They also reviewed the existing grading systems, including the WHO Classification 2005 (32)) and the binary system of classification (low-risk and high-risk) (suggested by Kujan et al. (12)) of oral dysplasia, both of which were blinded to the clinical diagnosis for their histological diagnosis. Statistical analysis revealed poor intraobserver variability with a p-value of 0.8 using the WHO classification and 0.3 using the binary classification. The binary classification, which is more likely to have higher concordance among pathologists, is recommended by the authors based on the results from the clinical standpoint. As pointed out by Nankiveli P et al. (36) and Jain A. et al. (37), the binary system potentially aids clinicians in decision-making regarding management strategies.

Another study was conducted by Manchanda A and Shetty DC (38), assessing inter- and intraobserver variability using the Smith C and Pindborg JJ (27) and WHO grading systems 1978 (29), along with the Brothwell grading system (22). A total of 45 histological tissues of dysplasia were examined, 15 each of mild, moderate, and severe dysplasia, and blindly graded by three observers using the three grading systems mentioned. The authors noted that the Brothwell system had significantly higher interobserver agreement than the WHO 1978 and Smith C and Pindborg JJ systems. Intraobserver agreement was similarly much greater in the Smith C and Pindborg JJ system, but predictability and the likelihood index were dispersed across a wider range in this system.

Every grading system has advantages, as well as disadvantages and limitations. Research teams continually improve their methods over time. For example, Smith C and Pindborg JJ (1969) is the oldest grading system for OED (27). Its disadvantage is that it is time-consuming and monotonous. It cannot explain why some non neoplastic lesions exhibit dysplasia signs. The WHO (1978) grading system (29) has limitations as it does not consider factors that determine malignant potential. The clinical relevance of distinguishing severe dysplasia from CIS remains unclear. Different observers may reach different conclusions. A study by Warnakulasuriya S. (39) highlights the need for more objective clinical and molecular biomarkers as histological grading of oral precancer's epithelial dysplasia in this system is subjective and may not reliably predict malignant potential. The WHO (2005) grading system also has limitations such as variations in oral epithelium thickness, the need for numeric values for statistical analyses, and the absence of malignant transformation risk factors.

Currently, the most widely used grading systems for OED are the Binary Grading System (2006) (12),(40) and WHO (2017). Most pathologists utilise both systems for dysplasia grading, but overall, pathologists tend to prefer the WHO (2017) grading system (34) due to its simplicity and ease of use. WHO (2017) also enhances the WHO (2005) classifications (32),(41). The main drawback of the Binary Grading system (2006) is that a large-scale study is necessary to verify the system’s reliability and reproducibility.

Computer-aided Diagnosis (CAD) of OED

The CAD is a system designed to assist doctors in interpreting medical images. The CAD system analyses digital images to identify typical features, such as diseases, and to highlight conspicuous sections to aid in making professional decisions. Now-a-days, CAD is considered the future application in digital pathology for examining Whole Slide Imaging (WSI) images and utilising Machine Learning (ML) algorithms. CAD is an interdisciplinary technique that combines AI and Computer Vision (CV) with image processing in pathology and radiology. Through CAD, tumours, polyps in the colon, dysplastic changes, and other abnormalities can be easily detected. CAD has been used clinically for over 40 years, but it does not substitute for doctors or professionals; instead, it plays a supportive role in medical diagnosis. In general, radiologists are responsible for interpreting medical images (42).

In the age of algorithms and AI, where computers can perform human-level tasks, defining risk may be far more significant based on how much human oversight is required (42). AI may play a key role in accurately predicting the development of oral cancer, but several methodological issues must be addressed concurrently with advances in AI algorithms for the latter to be applied to population-based detection protocols on a large scale (43). ML is a branch of AI (44) that focuses on using algorithms to solve various problems, such as data classification or regression, and is a growing area of interest for researchers looking to turn large amounts of data into knowledge that can be used in clinical decision-making. A recent advancement in ML is Deep Learning (DL) (45), which may more appropriately be referred to as a sub-part of ML (46). DL is suited to handling large data sets, making it capable of processing decision-making. DL systems find patterns that are useful for tasks other than those for which they were designed. DL-based pattern recognition software has successfully detected objects and classified images of various cancer diseases in medical image analysis. A diagnostic DL system should include information that can help it localise and explain its decision, just like a human can diagnose a disease based on the image features that inform the diagnosis.

Microscopic Images

Histology is the gold standard for confirming the detection and diagnosis of oral dysplasia. AI may assist pathologists in grading oral dysplasia (47). OED is predominantly diagnosed and graded based on architectural alterations and specific histologic features. Although AI has recently gained popularity in medical image analysis, only a few studies use traditional ML algorithms to diagnose oral precancerous and cancerous lesions (48). Deep Convolutional Neural Networks (CNNs), which are modern AI algorithms, have recently been the focus of research in digital pathology for CAD (49). The potential of these AI architectures in oral histological image analysis was demonstrated in some studies using CNNs and feature-based ML strategies (50). The image-based ML method is appropriate for grading oral dysplasia because the task is primarily based on distinguishing an object’s texture from the texture of its surroundings in an image. CNNs like Visual Geometry Group 16 (VGG16) (51), Residual Network (RestNet50) (52), and Inception-v3 (53) are helpful in several digital pathology studies (54), focusing on both feature extraction and image-based approaches.

Comparisons between two neural network architectures for distinguishing normal mucosa and unhealthy cells observed that VGG (80.66%) was more accurate in classifying tumour cells as opposed to healthy cells, and that ResNet (78.34%) was less accurate. The precision scores were as follows: VGG - 75.0%, ResNet - 72.4%, and F-Score - 77.6% and 75.5%, respectively (55).

Optical and Hyperspectral Images

The study of oral images using AI provides a method for the early and initial detection/diagnosis of certain abnormalities, offering ample scope for research. A study (56) on clinically annotated photographic images discovered that pre-processing with the VGG19 model significantly increased the classification accuracy of benign and precancerous tongue lesions to 98%.

In another study that applied a probabilistic Neural Network (NN), researchers were able to distinguish lichen planus from leukoplakia and normal tissues, achieving specificities of 81%, 74%, and 88%, respectively (57).

A Convolutional NN (CNN) strategy was employed to differentiate between normal and dysplastic tissue, followed by the use of a partitioned deep CNN that achieved 94.5% accuracy (58),(59). The latter work was conducted on hyperspectral images from the BioGPS University of California, Irvine (UCI) repository. Another study on hyperspectral images was carried out by Halicek M et al., who utilised tensor flow for classification and concluded that CNN (96.4%) had the highest accuracy in distinguishing between healthy tissue and cancerous tissue, followed by Support Vector Machine (SVM), Reinforcement Learning (RL), Differentiated Thyroid Carcinoma (DTC), Linear Discriminant Analysis (LDA) (67.4%) (60).

In their study (61), researchers explored the potential of CV and DL technology in photographic images of oral cancer. They investigated and identified OPMD using a 2-stage pipeline (oral lesion detection and oral lesion classification) through an automated system. In their preliminary real-time results, the authors achieved DL-based methods for automated detection and classification of oral cancer. The proposed model shows promise as a low-cost, non invasive tool to aid in OPMD screening and detection. The authors observed that U-Net models performed well in pixel-wise semantic segmentation, with the EfficientNet-b7 model receiving the highest dice score of 92.9%. YOLOv5l analyses the entire image for lesion regions and detects the lesion location within, while EfficientNet-b4 is used to classify the detected oral cancer lesions into multiple classes (Benign, OPMD, Carcinoma).

A study was conducted by Song B et al., to develop a low-cost, portable, easy-to-use system for the classification of oral dysplasia and malignancy images using various DL algorithms on a smartphone (62). Researchers in this study took photographs of the oral mucosa, gingiva, soft palate, vestibule, tongue, and floor of the mouth. A variety of DL methods were employed, including VGG-CNN-M, VGG-CNN-S, and VGG-16, with VGG-CNN-M achieving the highest average accuracy of 86.9% in 4-fold cross-validation when compared to the other two. The author proposed a two-stage method for computing oral histological images, utilising 12 layers deep CNN for the segmentation of their constituent layers. Random forests were trained on texture-based features (such as the Gabor filter) to detect keratin pearls from segmented keratin regions during both stages of the procedure.

A recent study by Rahman T and Mahanta LB focused on the precise segmentation of OED in oral cavity histopathological images, which is crucial for early diagnosis and treatment planning (63). They utilised DL-based methods such as U-Net and other transfer learning models like VGG16, VGG19, MobileNet, and DeepLabV3+ as backbones with U-Net for segmenting the oral cavity epithelium. The study compared the performance of these transfer learning models for accurate and precise segmentation of histopathology images. The vanilla U-Net model achieved the highest Intersection over Union (IoU) at 93.73% for oral epithelial segmentation.

In general, studies on the early detection of oral cancer will be greatly enhanced by the intervention of AI, and consequently, clinical practice will be more effective. Due to its ability to detect complex patterns, AI can automate many tasks. Therefore, research is essential to facilitate the interdisciplinary integration of such techniques, and advancements in this field may pave the way for future research.

Treatments

Every year, the American Cancer Society calculates new death and cancer incidence statistics for the US based on population-based data (64). There are over 500,000 new cases of oral cancer every year, associated with 350,000 deaths worldwide, making it one of the top ten most common cancers globally (24). Based on individual circumstances and dysplasia grading, treatments are offered. If someone has mild epithelial dysplasia and no urgent treatment is needed, a little bit of care is sufficient. However, in cases of moderate and severe epithelial dysplasia, treatment is recommended, often involving surgical removal of the patch or laser treatment. According to studies and clinician advice, Oral Dysplasia or OED can be managed with active treatment facilities (65),(66). Patients with medically compromised conditions or diffuse lesions may benefit from active treatment. Several methods are available for treating patients with OED that can prevent dysplasia from progressing to cancer (67). Many types of cancer occur on the floor of the mouth, on the tongue, gums, inside the cheek, and on the hard palate. In addition to more aggressive cancers, there are those that have spread into nearby tissues and those that have spread to nearby lymph nodes in the neck. A common treatment for oral dysplastic lesions is surgical excision with cold steel, laser, or cryosurgery. Surgery is preferred when small lesions progress from moderate to severe dysplasia. In South Asian countries, most people seek treatment late due to remote locations and socio-economic problems. Consequently, many patients’ treatments become complicated because they are highly associated with alcohol, smoking, gutka, and poor diets (68). Malignant transformation rates were higher among patients with untreated lesions (14.6% vs. 5.4%). Another study found that surgery increased the malignant transformation more than in non surgery patients (69). In their study, 59% of patients who underwent surgery had erythroplakia and non homogeneous leukoplakia, while 15% had non surgical treatment. Additionally, the majority of surgically treated lesions were found in high-risk areas, such as the floor of the mouth, the tongue, and the ventral tongue. Treatments for oral leukoplakia are becoming more accepted using laser surgery. The carbon dioxide laser is the most popular and extensively used for both excision and evaporation (70),(71). Cryosurgery is another method for treating OED patients, but it has some limitations. With or without OED, it plays a crucial role in managing oral leukoplakia. Cryosurgery has no tissue for examination, poor depth control, and significant postoperative pain and swelling (72). Some advantages of the cryosurgery method are that it is both bloodless and low-risk for infection, as well as relatively pain-free (73),(74). A study was conducted by (75) using cryogun cryotherapy for oral leukoplakia. They treated 72 patients with leukoplakia on the buccal mucosa, including 26 with mild, seven with moderate, and one with severe dysplasia, and eight lesions recurred. However, repeated treatment effectively controlled them at a mean follow-up time of 18 months. Finally, they showed that cryogun cryotherapy is more effective for oral leukoplakia treatments. Chemoprevention is another strategy for treating OPMD where medical therapies are used either topically or systemically. Several medications are considered chemopreventive agents, including genistein, resveratrol, S-allyl cysteine, diallyl sulfide, capsaicin, allicin, lycopene, curcumin, ellagic acid, lactacyl anethol, ursolic acid, silymarin, catechins, anethol, and eugenol (76). The Cochrane review from 2006 concluded that no chemoprevention agent helped prevent oral malignant transformation (77). According to Jerjes W et al., in a follow-up study using photodynamic therapy on an oral dysplastic lesion, 100% in mild, 82% in moderate, 81% in severe, and 69% in carcinoma-in-situ showed positive results (78). Especially for mild dysplasia, photodynamic therapy showed favourable results, but standardisation and formulation are problematic when determining the treatment protocol of photodynamic therapy. Photodynamic therapy is an ablative treatment that employs a photosensitising agent to destroy localised tissue and cells. The most studied chemopreventive agents are vitamins, especially retinoids, which are both natural and synthetic vitamin A derivatives (67),(79). In the area of chemoprevention of oral dysplasia, the use of Cyclooxygenase (COX) inhibitors remains of interest. Both oral dysplasia and H&N cancer are associated with the upregulation of COX-2 and Vascular Endothelial Growth Factor (VEGF) (80).

Radiation therapy is another method for treating oral cavity cancer. It plays an important role when general anaesthesia is not required, and normal anatomical functions are to be maintained. Radiotherapy treatment can be delivered through external beam radiation (teletherapy) with common side-effects, or through interstitial therapy (e.g., brachytherapy, plesiotherapy). Recent research suggests that new improvements in cancer imaging and radiation technology have allowed for more precise treatment administration, leading to more remarkable survival rates and a reduction in the detrimental effects of radiation (81). Radiation therapy is referred to as radical radiation therapy when used solely for cancer treatment. Patients with early-stage cancer typically receive only radical radiotherapy; however, patients with unresectable or advanced cancer may receive radiotherapy in combination with chemotherapy or targeted therapy using monoclonal antibodies against the Epidermal Growth Factor Receptor (EGFR) to enhance the cytotoxic effect of radiation. Adjuvant radiation therapy is used following surgery, while palliative radiation therapy is used to alleviate cancer symptoms. A study by Awadallah M et al., discussed the rationale behind radiation therapy to eradicate any microscopic tumour burden that may remain in the surgical field and to prevent recurrence (82). Radiation therapy involving electromagnetic fields consists of electrons and photons, with the latter treatment being the most popular for treating oral cancers. The most common primary treatment is surgery, which has a high rate of treatment success, with overall survival rates reaching 75-90 percent in early stages (83). Radiation therapy may include particle therapy, which uses protons, neutrons, or ions with a large electrical charge, such as helium. Intensity-modulated radiation therapy is another form of radiation therapy used for treating oral cancers. Radiation treatment can be used as either a primary treatment or as an adjunct to surgery.

Conclusion

The OED is a precancerous lesion, not cancer. It is a condition where abnormal cell growth occurs. The present article broadly discusses various histological grading methods provided by different scholars and authors to propose an ideal system for OED grading. However, each system has constraints that limit its application in everyday situations. Among all these grading systems, the WHO 2017 grading system is the most accepted and utilised by pathologists for OED grading during treatments. Nonetheless, there are still many limitations to it, making it challenging for oral pathologists to precisely detect the progression of OED and arrive at a proper diagnosis. A deeper understanding of the molecular mechanisms involved in malignant development should help predict which patients are most likely to experience changes. Histopathological assessment of the severity of OED remains the gold standard for predicting the malignant transformation of precancerous lesions. People should be aware of various highly dangerous risk factors that may lead to death. The treatment of OED or oral cancer remains challenging. AI is paving the way for a more streamlined healthcare system and offering virtually endless possibilities for cancer treatment. Pathologists are not to be replaced by AI. Instead, pathologists hope that AI will bring precision to oral oncology and oncologic pathology with rapid recommendations and automated assistance. The article also discusses three main types of treatments: surgery, chemotherapy, and radiation. However, surgery remains the only viable treatment option, despite its significant functional implications. More research is needed to develop a reliable and reproducible method for grading OED using AI and exploring treatment options. The present research should focus on the system’s predictive value, relevance, applicability, and feasibility for a better understanding. Finally, it is evident that AI-based studies are lacking in the field of OED, particularly at the microscopic level.

References

1.
Jin LJ, Lamster IB, Greenspan JS, Pitts NB, Scully C, Warnakulasuriya S. Global burden of oral diseases: Emerging concepts, management and interplay with systemic health. Oral Dis. 2016;22(7):609-19. [crossref]
2.
Petersen PE, Bourgeois D, Ogawa H, Estupinan-Day S, Ndiaye C. The global burden of oral diseases and risks to oral health. Bull World Health Organ. 2005;83(9):661-69.
3.
Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, et al. Effect of screening on oral cancer mortality in Kerala, India: A cluster-randomised controlled trial. Lancet. 2005;365(9475):1927-33. [crossref]
4.
Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12-49. [crossref]
5.
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):07-33. [crossref]
6.
Borse V, Konwar AN, Buragohain P. Oral cancer diagnosis and perspectives in India. Sens Int. 2020;1:100046. [crossref]
7.
Dye BA, Tan S, Smith V, Lewis BG, Barker LK, Thornton-Evans G, et al. Trends in oral health status: United States, 1988-1994 and 1999-2004. Vital Health Stat 11. 2007;(248):01-92.
8.
Rastogi V, Puri N, Mishra S, Arora S, Kaur G, Yadav L. An insight to oral epithelial dysplasia. Int J Head Neck Surg. 2013;4(2):74-82. [crossref]
9.
Sharma N, Hosmani JV, Tiwari V. Epithelial Dysplasia: Different grading system and its applications. J Int Oral Heal. 2010;2(1):101-05.
10.
Salehiniya H, Raei M. Oral cavity and lip cancer in the world: An epidemiological review. Biomed Res Ther. 2020;7(8):3898-905. [crossref]
11.
Masthan KMK, Rajesh E, Tamilarasi U, Anitha N. Grading of oral epithelial dysplasia- A review. Biomed Pharmacol J. 2016;9(2):833-35. [crossref]
12.
Kujan O, Oliver RJ, Khattab A, Roberts SA, Thakker N, Sloan P. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol. 2006;42(10):987-93. [crossref]
13.
Abbey LM, Kaugars GE, Gunsolley JC, Burns JC, Page DG, Svirsky JA, et al., Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;80(2):188-91. [crossref]
14.
Brown LM, Gridley G, Diehl SR, Winn DM, Harty LC, Otero EB, et al. Family cancer history and susceptibility to oral carcinoma in Puerto Rico. Cancer. 2001;92(8):2102-08. 3.0.CO;2-9>[crossref]
15.
Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, Bagan JV, González-Moles MA, Kerr AR, et al. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. 2021;27(8):1862-80. [crossref]
16.
Pires FR, Barreto MEZ, Nunes JGR, Car-Neiro NS, de Azevedo AB, Dos Santos TCRB. Oral potentially malignant disorders: Clinical-pathological study of 684 cases diagnosed in a brazilian population. Med Oral Patol Oral y Cir Bucal. 2020;25(1):e84-e88. [crossref]
17.
Reagan JW. The cellular morphology. Cancer. 1953;6:224-35.3.0.CO;2-H>[crossref]
18.
Reibel J, Gale N, Hille J, Hunt JL, Lingen M, Muller S, et al. Oral potentially malignant disorders and oral epithelial dysplasia. WHO Classif Head Neck Tumours. 2017;4:112-15.
19.
Bhargava A, Saigal S, Chalishazar M. Histopathological grading systems in oral squamous cell carcinoma: A review. J Int Oral Health. 2010;2(4):01-10.
20.
Van Der Waal I, Schepman KP, Van Der Meij EH, Smeele LE. Oral leukoplakia: A clinicopathological review. Oral Oncol. 1997;33(5):291-301. [crossref]
21.
- Bouquot JE, Speight PM, Farthing PM. Epithelial dysplasia of the oral mucosa Diagnostic problems and prognostic features. Curr Diagnostic Pathol. 2006;12(1):11-21. [crossref]
22.
Brothwell DJ, Lewis DW, Bradley G, Leong I, Jordan RCK, Mock D, et al. Observer agreement in the grading of oral epithelial dysplasia. Community Dent Oral Epidemiol. 2003;31(4):300-05. [crossref]
23.
Tilakaratne WM, Jayasooriya PR, Jayasuriya NS, De Silva RK. Oral epithelial dysplasia: Causes, quantification, prognosis, and management challenges. Periodontol 2000. 2019;80(1):126-47. [crossref]
24.
Camalan S, Mahmood H, Binol H, Araújo ALD, Santos-Silva AR, Vargas PA, et al. Convolutional neural network-based clinical predictors of oral dysplasia: Class activation map analysis of deep learning results. Cancers (Basel). 2021;13(6):1291. [crossref]
25.
Odell E, Kujan O, Warnakulasuriya S, Sloan P. Oral epithelial dysplasia: Recognition, grading and clinical significance. Oral Dis. 2021;27(8):1947-76. [crossref]
26.
Sheng J, Xiang Y, Shang L, He Q. Molecular alterations and clinical relevance in cervical carcinoma and precursors (Review). Oncol Rep. 2020;44(6):2397-405. [crossref]
27.
Smith C, Pindborg JJ. Histological grading of oral epithelial atypia by the use of photographic standards. C. Hamburgers Bogtrykkeri 1969;5-30.
28.
Waldron CA, Shafer WG. Leukoplakia revisited. A clinicopathologic study 3256 oral leukoplakias. Cancer. 1975;36(4):1386-92. 3.0.CO;2-7>[crossref]
29.
Kramer IR, Lucas RB, Pindborg JJ, Sobin LH. Definition of leukoplakia and related lesions: An aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol. 1978;46(4):518-39. [crossref]
30.
Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79(3):321-29. [crossref]
31.
Žerdoner D. The Ljubljana classification- Its application to grading oral epithelial hyperplasia. J Craniomaxillofac Surg. 2003;31(2):75-79. [crossref]
32.
Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization Classification of tumors: Pathology and genetics of tumors of the head and neck. IARC Press, Lyon. 2005.
33.
Gale N, Blagus R, El-Mofty SK, Helliwell T, Prasad ML, Sandison A, et al. Evaluation of a new grading system for laryngeal squamous intraepithelial lesions-a proposed unified classification. Histopathology. 2014;65(4):456-64. [crossref]
34.
Sloan P, Gale N, Hunter K, et al. Malignant surface epithelial tumours: Squamous cell carcinoma. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, et al., editors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press; 2017.
35.
Shubhasini AR, Praveen BN, Hegde U, Uma K, Shubha G, et al. Inter- and intraobserver variability in diagnosis of oral dysplasia. Asian Pacific J Cancer Prev. 2017;18(12):3251-54.
36.
Nankivell P, Williams H, Matthews P, Suortamo S, Snead D, McConkey C, et al. The binary oral dysplasia grading system: Validity testing and suggested improvement. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115(1):87-94. [crossref]
37.
Jain A, Chandurkar KP, Umale V, Srivastava R. Dysplasia in oral cavity: A review. Int J Oral Health Med Res. 2016;2(6):107-09.
38.
Manchanda A, Shetty DC. Reproducibility of grading systems in oral epithelial dysplasia. Med Oral Patol Oral Cir Bucal. 2017;17(6):e935-42. Available from: https://doi.org/10.4317/medoral.17749. [crossref]
39.
Warnakulasuriya S. Histological grading of oral epithelial dysplasia: Revisited. J Pathol. 2001;194(3):294-97. 3.0.CO;2-Q>[crossref]
40.
Kai HC, Ar MS, Iini MA. A critical evaluation of epithelial dysplasia in oral mucosal lesions using the Smith-Pindborg method of standardization. J Oral Pathol. 1985;14(6):476-82. [crossref]
41.
Gnepp DR (2005). WHO Classification of Tumours, 3rd Edition, Volume 9. Pathology and genetics of head and neck tumours. Edited by Barnes L, Eveson JW, Reichart P, Sidransky D. PP-242.
42.
Oakden-Rayner L. The rebirth of CAD: How is modern AI different from the CAD we know? Radiol Artif Intell. 2019;1(3):e180089. [crossref]
43.
García-Pola M, Pons-Fuster E, Suárez-Fernández C, Seoane-Romero J, Romero-Méndez A, López-Jornet P. Role of artificial intelligence in the early diagnosis of oral cancer. A scoping review. Cancers (Basel). 2021;13(18):4600. [crossref]
44.
Mahmood H, Shaban M, Rajpoot N, Khurram SA. Artificial Intelligence-based methods in head and neck cancer diagnosis: An overview. Br J Cancer. 2021;124:1934-40. [crossref]
45.
Lecun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521(7553):436-44.[crossref]
46.
Cuocolo R, Caruso M, Perillo T, Ugga L, Petretta M. Machine Learning in oncology: A clinical appraisal. Cancer Lett. 2020;481:55-62 [crossref]
47.
Sultan AS, Elgharib MA, Tavares T, Jessri M, Basile JR. The use of artificial intelligence, machine learning and deep learning in oncologic histopathology. J Oral Pathol Med. 2020;49(9):849-56. [crossref]
48.
Mahmood H, Shaban M, Indave BI, Santos-Silva AR, Rajpoot N, Khurram SA. Use of artificial intelligence in diagnosis of head and neck precancerous and cancerous lesions: A systematic review. Oral Oncol. 2020;110:104885. [crossref]
49.
Komura D, Ishikawa S. Machine Learning methods for histopathological image analysis. Comput Struct Biotechnol J. 201816:34-42. [crossref]
50.
Baik J, Ye Q, Zhang L, Poh C, Rosin M, MacAulay C, et al. Automated classification of oral premalignant lesions using image cytometry and Random Forests-based algorithms. Cell Oncol (Dordr). 2014;37(3):193-202. [crossref]
52.
Pravitasari AA, Iriawan N, Almuhayar M, Azmi T, Irhamah, Fithriasari K, et al. UNet-VGG16 with transfer learning for MRI-based brain tumour segmentation. Telkomnika Telecommunication Comput Electron Control. 2020;18(3):1310-18. [crossref]
52.
He K, Zhang X, Ren S, Sun J. Deep residual learning for image recognition. 2015;51:55. [crossref]
53.
Nguyen PTH, Sakamoto K, Ikeda T. Deep-learning application for identifying histological features of epithelial dysplasia of tongue. J Oral Maxillofac Surgery, Med Pathol. 2022;34(4):514-22.[crossref]
54.
Pantanowitz L. Digital images and the future of digital pathology. J Pathol Inform. 2010;1:15. [crossref]
55.
Wieslander H, Forslid G, Bengtsson E, Wählby C, Hirsch JM, Stark CR, et al. Deep convolutional neural networks for detecting cellular changes due to malignancy. Proc- 2017 IEEE Int Conf Comput Vis Work ICCVW. 2017 2018-Janua:82-89. [crossref]
56.
Shamim MZM, Syed S, Shiblee M, Usman M, Ali SJ, Hussein HS, et al. Automated detection of oral pre-cancerous tongue lesions using deep learning for early diagnosis of oral cavity cancer. Comput J. 2022;65:91–104. [crossref]
57.
Jurczyszyn K, Gedrange T, Kozakiewicz M. Theoretical background to automated diagnosing of oral leukoplakia: A preliminary report. J Healthc Eng. 2020;2020:8831161. Available from: https://doi.org/10.1155/2020/8831161. [crossref]
58.
Fu Q, Chen Y, Li Z, Jing Q, Hu C, Liu H, et al. A deep learning algorithm for detection of oral cavity squamous cell carcinoma from photographic images: A retrospective study. E Clinical Medicine. 2020;27:100558. [crossref]
59.
Jeyaraj PR, Samuel Nadar ER. Computer-assisted medical image classification for early diagnosis of oral cancer employing deep learning algorithm. J Cancer Res Clin Oncol. 2019;145(4):829-37. [crossref]
60.
Halicek M, Lu G, Little JV, Wang X, Patel M, Griffith CC, et al. Deep convolutional neural networks for classifying head and neck cancer using hyperspectral imaging. J Biomed Opt. 2017;22(6):060503. [crossref]
61.
Tanriver G, Soluk Tekkesin M, Ergen O. Automated detection and classification of oral lesions using deep learning to detect oral potentially malignant disorders. Cancers (Basel). 2021;13(11):2766. Available from: https://doi.org/10.3390/ cancers13112766. [crossref]
62.
Song B, Sunny S, Uthoff RD, Patrick S, Suresh A, Kolur T, et al. Automatic classification of dual-modalilty, smartphone-based oral dysplasia and malignancy images using deep learning. Biomed Opt Express. 2018;9(11):5318-29. [crossref]
63.
Rahman T, Mahanta LB. Evaluating the deep learning models performance for segmentation of oral epithelial dysplasia: A histological data-driven approach. Prabha Mater Sci Lett. 2024;3(1):94-104. [crossref]
64.
Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17-48. [crossref]
65.
Jaber MA, Elameen EM. Long-term follow-up of oral epithelial dysplasia: A hospital based cross-sectional study. J Dent Sci. 2021;16(1):304-10. [crossref]
66.
Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002;52(4):195-215. [crossref]
67.
Nankivell P, Mehanna H. Oral dysplasia: Biomarkers, treatment, and follow-up. Curr Oncol Rep. 2011;13(2):145-52. [crossref]
68.
Heck JE, Marcotte EL, Argos M, Parvez F, Ahmed A, Islam T, et al. Betel quid chewing in rural Bangladesh: Prevalence, predictors and relationship to blood pressure. Int J Epidemiol. 2012;41(2):462-71. [crossref]
69.
Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol. 2006;42(5):461-74. [crossref]
70.
Frame JW. Removal of oral soft tissue pathology with the CO2 laser. J Oral Maxillofac Surg. 1985;43(11):850-55. [crossref]
71.
Balasundaram I, Payne KFB, Al-Hadad I, Alibhai M, Thomas S, Bhandari R. Is there any benefit in surgery for potentially malignant disorders of the oral cavity? J Oral Pathol Med. 2014;43(4):239-44. [crossref]
72.
Ishii J, Fujita K, Komori T. Laser surgery as a treatment for oral leukoplakia. Oral Oncol. 2003;39(8):759-69. [crossref]
73.
Ebenezer V, Ramalingam B. Cryosurgery in the management of maxillofacial lesions: A review literature. Eur J Mol Clin Med. 2020;7:1885-89.
74.
Rezende KM, Moraes P de C, Oliveira LB, Thomaz LA, Junqueira JLC, Bönecker M. Cryosurgery as an effective alternative for treatment of oral lesions in children. Braz Dent J. 2014;25(4):352-56. [crossref]
75.
Chen HM, Cheng SJ, Lin HP, Yu CH, Wu YC, Chiang CP. Cryogun cryotherapy for oral leukoplakia and adjacent melanosis lesions. J Oral Pathol Med. 2015;44(8):607-13. [crossref]
76.
Dorai T, Aggarwal BB. Role of chemopreventive agents in cancer therapy. Cancer Lett. 2004;215(2):129-40. [crossref]
77.
Lodi G, Franchini R, Warnakulasuriya S, Varoni EM, Sardella A, Kerr AR, et al. Interventions for treating oral leukoplakia to prevent oral cancer. Cochrane Database Syst Rev. 2016;7(7):CD001829. Available from: https://doi. org/10.1002/14651858.CD001829.pub4. [crossref]
78.
Jerjes W, Upile T, Hamdoon Z, Mosse CA, Akram S, Hopper C. Photodynamic therapy outcome for oral dysplasia. Lasers Surg Med. 2011;43(3):192-99. [crossref]
79.
Baglietto L, Torrisi R, Arena G, Tosetti F, Gonzaga AG, Pasquetti W, et al. Ocular effects of fenretinide, a vitamin A analog, in a chemoprevention trial of bladder cancer. Cancer Detect Prev. 2000;24(4):369-75.
80.
Renkonen J, Wolff H, Paavonen T. Expression of cyclo-oxygenase-2 in human tongue carcinoma and its precursor lesions. Virchows Arch. 2002;440(6):594-97. [crossref]
81.
Cabrera-Rodríguez JJ. The role of radiotherapy in the treatment of oral cavity cancer. Plast Aesthetic Res. 2016;3:158-66. [crossref]
82.
Awadallah M, Nisi K, Patel KJ. Factors Affecting Response and Survival in Radiotherapy. In: Kademani, D. (eds) Improving Outcomes in Oral Cancer. Springer, Cham. 2020; 105-15. Available from: https://doi.org/10.1007/978-3- 030-30094-4_8. [crossref]
83.
Stathopoulos P, Smith WP. Analysis of survival rates following primary surgery of 178 consecutive patients with oral cancer in a large district general hospital. J Maxillofac Oral Surg. 2017;16(2):158-63. [crossref]

Tables and Figures
[Table / Fig - 1]
DOI and Others

DOI: 10.7860/JCDR/2024/71109.19727

Date of Submission: Apr 08, 2024
Date of Peer Review: Jun 19, 2024
Date of Acceptance: Jun 27, 2024
Date of Publishing: Aug 01, 2024

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Apr 09, 2024
• Manual Googling: Jun 21, 2024
• iThenticate Software: Jun 26, 2024 (12%)

ETYMOLOGY: Author Origin

EMENDATIONS: 5

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com